How does an information center that’s been functioning for 20+ years make the shift to a fully digital experience? Look no further than Chiesi Pharmaceuticals.

The Chiesi library, based at the company’s European headquarters in Parma Italy, serves the research and development group, but it has evolved over time to satisfy the needs of marketing and business development. Still, at the heart of the library is scientific content.

Prior to launching RightFind, the library team of four information professionals was bogged down with individual employee requests for access to content. It was clear: processing thousands of email requests for content wasn’t scalable or efficient. They needed to figure out ”a new way of working.”

That new way of working came in the form of content management solution RightFind Enterprise — a tool for finding, accessing, buying, and collaborating on scientific content in a copyright compliant way.

Today, Chiesi users know that by using RightFind they now have a one-stop-shop to check access to resources and retrieve content efficiently and cost-effectively. Users are able to take full advantage of the subscribed journals, books and other content that have been made available to them whether they are in the office, on the road or at home.

Für Kollegen, die regelmäßig wissenschaftliche Arbeiten veröffentlichen, ist das Cite It-Tool praktisch, um Bibliografien automatisch mit einer Vielzahl unterschiedlicher Stil- und Zitieroptionen zu formatieren. Verschiedene Abteilungen, zum Beispiel die medizinische Informationsabteilung, haben jetzt Kollaborationsräume namens Shared Libraries eingerichtet, sodass jeder im Team Hervorhebungen und Anmerkungen in Dokumenten sehen kann.

Gisella Lo Presti Library Team, Chiesi

About Chiesi

Headquartered in Parma, Italy, Chiesi Farmaceutici is an international research-focused Healthcare group with more than 80 years of experience in the pharmaceutical industry. The privately-owned company has a strong focus on research, development, production and the commercialization of innovative medicines in therapeutic areas that include: respiratory, cardiovascular, neonatology, and cystic fibrosis.

More case studies